KV PHARMACEUTICAL CO /DE/
S-8, EX-5, 2000-10-19
PHARMACEUTICAL PREPARATIONS
Previous: KV PHARMACEUTICAL CO /DE/, S-8, 2000-10-19
Next: KV PHARMACEUTICAL CO /DE/, S-8, EX-23, 2000-10-19





                                October 19, 2000



Board of Directors
K-V Pharmaceutical Company
2503 South Hanley Road
St. Louis, Missouri  63144

         Re:      Registration Statement on Form S-8

Gentlemen:

         We have served as counsel to K-V Pharmaceutical Company (the "Company")
in  connection  with the  various  legal  matters  relating  to the  filing of a
registration  statement  on Form S-8 (the  "Registration  Statement")  under the
Securities Act of 1933, as amended,  and the Rules and  Regulations  promulgated
thereunder,  relating to (a) 75,000  shares of Class A Common  Stock,  par value
$.01 per share, 150,000 shares of Class B Common Stock, par value $.01 per share
(collectively,  the "Executive Common Stock"),  which Executive Common Stock has
been  issued  pursuant  to, or, in the case of shares  subject to  options,  are
reserved for  issuance  pursuant to an  employment  agreement  (the  "Employment
Agreement")  dated as of  December  16,  1996  between  the  Company and Marc S.
Hermelin  (the  "Executive"),  as amended;  and (b) 500 shares of Class A Common
Stock, (the "Consulting Common Stock"),  which the Company is obligated to issue
(and  intends to issue  promptly  after the  effectiveness  of the  Registration
Statement) pursuant  to a  Consulting  Agreement  dated as of  October  1,  2000
("Consulting  Agreement")  between  the  Company  and Laura  Kragie,  M.D.  (the
"Consultant").  The Executive  Common Stock and the Consulting  Common Stock are
herein referred to collectively as the "Shares."

         We have examined such corporate  records of the Company,  such laws and
such other  information  as we have deemed  relevant,  including  the  Company's
Certificate  of  Incorporation,  as  amended,  and Bylaws,  as amended,  certain
resolutions  adopted by the Board of  Directors  of the Company  relating to the
Employment  Agreement and Consulting  Agreement and  certificates  received from
state officials and from officers of the Company. In delivering this opinion, we
have  assumed  the  genuineness  of  all  signatures,  the  authenticity  of all
documents  submitted to us as originals,  the conformity to the originals of all
documents submitted to us as certified, photostatic or conformed copies, and the
correctness of all statements submitted to us by officers of the Company.

         Based upon the foregoing, we are of the opinion that:

         1. The Company is a corporation duly incorporated, validly existing and
in good standing under the laws of the State of Delaware.

         2. All Shares  issued  pursuant to the  Employment  Agreement  are duly
authorized,  validly  issued,  fully  paid  and  nonassessable,  and all  Shares
reserved  for issuance  pursuant to the  Employment  Agreement,  or to be issued
pursuant  to  the  Consulting  Agreement,  if  issued  in  accordance  with  the
Employment  Agreement  or the  Consulting  Agreement as the case may be, will be
duly authorized, validly issued, fully paid and nonassessable.

         We consent to the use of this opinion as an exhibit to the Registration
Statement  and to the use of our  name in the  Registration  Statement.  We also
consent to your filing copies of this opinion as an exhibit to the  Registration
Statement  with  agencies of such states as you deem  necessary in the course of
complying  with the laws of such  states  regarding  the  offer  and sale of the
Shares.

                                            Very truly yours,

                                            /s/ Gallop, Johnson & Neuman, L.C.

                                            GALLOP, JOHNSON & NEUMAN, L.C.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission